Publications

Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

Download PDF
Resource: Intracranial injection of NK cells engineered with a HER2-targeted chimeric antigen receptor in patients with recurrent glioblastoma

.

Related Articles

Spatial genomic, biochemical, and cellular mechanisms drive meningioma heterogeneity and evolution

Link
Multiplex protein imaging in tumour biology

Link